351 related articles for article (PubMed ID: 32390303)
1. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract][Full Text] [Related]
4. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
Yuan Y; Ye HQ; Ren QC
Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
6. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
[TBL] [Abstract][Full Text] [Related]
7. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
[TBL] [Abstract][Full Text] [Related]
8. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.
Smit MA; Geiger TR; Song JY; Gitelman I; Peeper DS
Mol Cell Biol; 2009 Jul; 29(13):3722-37. PubMed ID: 19414595
[TBL] [Abstract][Full Text] [Related]
9. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
10. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
Serafim Junior V; Fernandes GMM; Oliveira-Cucolo JG; Pavarino EC; Goloni-Bertollo EM
Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
[TBL] [Abstract][Full Text] [Related]
11. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
Jia S; Wang W; Hu Z; Shan C; Wang L; Wu B; Yang Z; Yang X; Lei D
Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
13. Schwann cells promote EMT and the Schwann-like differentiation of salivary adenoid cystic carcinoma cells via the BDNF/TrkB axis.
Shan C; Wei J; Hou R; Wu B; Yang Z; Wang L; Lei D; Yang X
Oncol Rep; 2016 Jan; 35(1):427-35. PubMed ID: 26530352
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.
Okugawa Y; Tanaka K; Inoue Y; Kawamura M; Kawamoto A; Hiro J; Saigusa S; Toiyama Y; Ohi M; Uchida K; Mohri Y; Kusunoki M
Br J Cancer; 2013 Jan; 108(1):121-30. PubMed ID: 23175149
[TBL] [Abstract][Full Text] [Related]
15. Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis.
Smit MA; Peeper DS
Oncogene; 2011 Sep; 30(35):3735-44. PubMed ID: 21478908
[TBL] [Abstract][Full Text] [Related]
16. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
17. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.
Wang Z; Hulsurkar M; Zhuo L; Xu J; Yang H; Naderinezhad S; Wang L; Zhang G; Ai N; Li L; Chang JT; Zhang S; Fazli L; Creighton CJ; Bai F; Ittmann MM; Gleave ME; Li W
Neoplasia; 2021 Nov; 23(11):1147-1165. PubMed ID: 34706306
[TBL] [Abstract][Full Text] [Related]
18. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
Abbaci A; Talbot H; Saada S; Gachard N; Abraham J; Jaccard A; Bordessoule D; Fauchais AL; Naves T; Jauberteau MO
Oncogene; 2018 Feb; 37(6):756-767. PubMed ID: 29059151
[TBL] [Abstract][Full Text] [Related]
20. MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
Gao L; Yan P; Guo FF; Liu HJ; Zhao ZF
Neoplasma; 2018; 65(1):89-96. PubMed ID: 29322793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]